References
  1. Colpaert RM, Ramseyer AM, Luu T, Quick CM, Frye LT, Magann EF. Diagnosis and Management of Placental Mesenchymal Disease. A Review of the Literature. Obstet Gynecol Surv. 2019;74(10):611-622. doi:10.1097/OGX.0000000000000716
  2. Oide S, Kuwata T, Wang L, Imai K, Chikazawa K, Takagi K. Placental mesenchymal dysplasia with a good outcome: A case report. J of Obstet and Gynaecol. 2019;45(11):2284-2288. doi:10.1111/jog.14095
  3. Nayeri UA, West AB, Grossetta Nardini HK, Copel JA, Sfakianaki AK. Systematic review of sonographic findings of placental mesenchymal dysplasia and subsequent pregnancy outcome. Ultrasound Obstet Gynecol. 2013;41(4):366-374. doi:10.1002/uog.12359
  4. Korevaar TI, Steegers EA, de Rijke YB, et al. Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study. Eur J Epidemiol. 2015;30(9):1057-1066. doi:10.1007/s10654-015-0039-0
  5. Olajide F, Kitau MJ, Chard T. Maternal serum AFP levels in the first trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol. 1989;30(2):123-128. doi:10.1016/0028-2243(89)90058-0
  6. Kodera C, Aoki S, Ohba T, et al. Clinical manifestations of placental mesenchymal dysplasia in Japan: A multicenter case series. J of Obstet and Gynaecol. 2021;47(3):1118-1125. doi:10.1111/jog.14647
  7. Gupta M, Vang R, Yemelyanova AV, et al. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists. Am J Surg Pathol. 2012;36(12):1747-1760. doi:10.1097/PAS.0b013e31825ea736
  8. Cohen MC, Roper EC, Sebire NJ, Stanek J, Anumba DO. Placental mesenchymal dysplasia associated with fetal aneuploidy. Prenat Diagn. 2005;25(3):187-192. doi:10.1002/pd.1103
  9. McConnell TG, Norris-Kirby A, Hagenkord JM, Ronnett BM, Murphy KM. Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am J Surg Pathol. 2009;33(9):1409-1415. doi:10.1097/PAS.0b013e3181a90e01
  10. Marusik C, Frykholm C, Ericson K, Wikström J, Axelsson O. Diagnosis of placental mesenchymal dysplasia with magnetic resonance imaging.Ultrasound in Obstet & Gyne. 2017;49(3):410-412. doi:10.1002/uog.15930
  11. Himoto Y, Kido A, Minamiguchi S, et al. Prenatal differential diagnosis of complete hydatidiform mole with a twin live fetus and placental mesenchymal dysplasia by magnetic resonance imaging. J Obstet Gynaecol Res. 2014;40(7):1894-1900. doi:10.1111/jog.12441
  12. Wang KH, Kupa J, Duffy KA, Kalish JM. Diagnosis and Management of Beckwith-Wiedemann Syndrome. Front Pediatr. 2020;7:562. Published 2020 Jan 21. doi:10.3389/fped.2019.00562
  13. Ishikawa S, Morikawa M, Yamada T, Akaishi R, Kaneuchi M, Minakami H. Prospective risk of stillbirth in women with placental mesenchymal dysplasia. J of Obstet and Gynaecol. 2015;41(10):1562-1568. doi:10.1111/jog.12757
  14. Simeone S, Franchi C, Marchi L, et al. Management of placental mesenchymal dysplasia associated with fetal anemia and IUGR. Eur J Obstet Gynecol Reprod Biol. 2015;184:132-134. doi:10.1016/j.ejogrb.2014.09.024